Novel Immunotherapies for Osteosarcoma
Osteosarcoma (OS) is the most common primary malignant bone sarcoma mainly affecting adolescents and young adults, which often progresses to pulmonary metastasis and leads to the death of OS patients. OS is characterized as a highly heterogeneous cancer type and the underlying pathologic mechanisms...
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Frontiers Media S.A.
2022-04-01
|
| Schriftenreihe: | Frontiers in Oncology |
| Schlagworte: | |
| Online Zugang: | https://www.frontiersin.org/articles/10.3389/fonc.2022.830546/full |